Healthcare provider profile · identity verified

David M Roll, M.D.

Internal Medicine · REVERE, MA · NPI 1194824417

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	378	100
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	286	31
Gabapentin	Gabapentin	260	48
Metoprolol Succinate	Metoprolol Succinate	250	68
Omeprazole	Omeprazole	242	64
Amlodipine Besylate	Amlodipine Besylate	227	65
Albuterol Sulfate Hfa	Albuterol Sulfate	220	62
Lisinopril	Lisinopril	214	67
Trulicity	Dulaglutide	188	27
Metformin Hcl	Metformin Hcl	167	49
Levothyroxine Sodium	Levothyroxine Sodium	135	38
Losartan Potassium	Losartan Potassium	128	40
Fluticasone Propionate	Fluticasone Propionate	125	42
Oxycodone Hcl	Oxycodone Hcl	116	22
Jardiance	Empagliflozin	112	30
Tamsulosin Hcl	Tamsulosin Hcl	107	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	99	11
Famotidine	Famotidine	93	31
Trazodone Hcl	Trazodone Hcl	92	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	91	suppressed
Pravastatin Sodium	Pravastatin Sodium	88	25
Sertraline Hcl	Sertraline Hcl	86	25
Clonazepam	Clonazepam	75	suppressed
Tramadol Hcl	Tramadol Hcl	75	13
Eliquis	Apixaban	74	19
Ibuprofen	Ibuprofen	74	24
Ozempic	Semaglutide	74	15
Diclofenac Sodium	Diclofenac Sodium	73	26
Rosuvastatin Calcium	Rosuvastatin Calcium	71	26
Tizanidine Hcl	Tizanidine Hcl	70	16
Lorazepam	Lorazepam	69	14
Pantoprazole Sodium	Pantoprazole Sodium	66	17
Simvastatin	Simvastatin	66	22
Furosemide	Furosemide	63	22
Incruse Ellipta	Umeclidinium Bromide	62	21
Quetiapine Fumarate	Quetiapine Fumarate	61	18
Hydrochlorothiazide	Hydrochlorothiazide	59	20
Pregabalin	Pregabalin	58	suppressed
Metformin Hcl Er	Metformin Hcl	57	23
Finasteride	Finasteride	52	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	16
Meloxicam	Meloxicam	49	18
Mounjaro	Tirzepatide	49	suppressed
Naproxen	Naproxen	48	15
Citalopram Hbr	Citalopram Hydrobromide	46	suppressed
Montelukast Sodium	Montelukast Sodium	46	15
Chlorthalidone	Chlorthalidone	41	12
Carvedilol	Carvedilol	40	15
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	12
Ventolin Hfa	Albuterol Sulfate	36	12
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	33	suppressed
Spironolactone	Spironolactone	33	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Hydrocortisone	Hydrocortisone	32	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	12
Lidocaine	Lidocaine	32	suppressed
Topiramate	Topiramate	32	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	30	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Prednisone	Prednisone	30	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Allopurinol	Allopurinol	28	suppressed
Arnuity Ellipta	Fluticasone Furoate	28	suppressed
Methadone Hcl	Methadone Hcl	27	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Lovastatin	Lovastatin	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Cyclosporine	Cyclosporine	22	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Torsemide	Torsemide	19	suppressed
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Baclofen	Baclofen	15	suppressed
Glipizide	Glipizide	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Atenolol	Atenolol	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Nystatin	Nystatin	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Diazepam	Diazepam	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Zyprexa	Olanzapine	12	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Potassium Chloride	Potassium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error